All you need to know about NRx Pharmaceuticals!
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on creating novel therapeutics that use molecules to treat medical conditions with no approved cure. The Company’s lead product candidate is ZYESAMI™ (AVIPTADIL®) ZYESAMI™ (Aviptadil acetate), a synthetic Vasoactive Intestinal Peptide (VIP), which has...
